In the context of hepatic fibrosis, decreased β-arrestin2 has been shown to inhibit HSCs collagen production and TGF-β1-Smad2/3 pathway activation by elevating TGFBR3 expression 52. Here, TGFB1 is linked to Hepatic fibrosis.